Trial intelligence / Profile preview

Leuplin SR 11.25 mg Long-term Use Survey in Prostate Cancer (96 Weeks)

jRCT1080222509

Sponsor
Takeda
Start
Jun 2014
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Open-label, single-arm trial of leuprolide in prostate cancer (PCa), sponsored by Takeda.

02

Drugs

leuprolide
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on jRCT1080222509.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080222509.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call